Lenalidomide, bortezomib and dexamethasone followed by tandem- autologous stem cell transplantation is an effective treatment modality for multi-hit multiple myeloma

•We provide a recommendation for the treatment of multi-hit MM.•Lenalidomide has an advantage in improving the early ORR of multi-hit MM.•Tandem-ASCT can further prolong the long-term survival rate of multi-hit MM.•We analyzed factors affecting survival of MM with and without ASCT by univariate and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Leukemia research 2021-11, Vol.110, p.106710-106710, Article 106710
Hauptverfasser:	Tang, Shanhao, Lu, Yin, Zhang, Pisheng, Chen, Dong, Liu, Xuhui, Du, Xiaohong, Cao, Junjie, Ye, Peipei, Chen, Lieguang, Li, Shuangyue, Sha, Keya, Zhuang, Xian xu, Xie, Yiyu, Wu, Xiaojin, Pei, Renzhi
Format:	Artikel
Sprache:	eng
Schlagworte:	Autologous stem cell transplantation Lenalidomide Multi-hit Multiple myeloma Prognosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!